Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adeel A Butt

Showing results (31-40 of 254) with videos related to

Pageof 26
Sort By:
The American Journal of the Medical Sciences|May 17, 2007
Biochemical and virologic parameters in patients co-infected with hepatitis C and HIV versus patients with hepatitis C mono-infectionAdeel A Butt, Joel Tsevat, Jawad Ahmad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2012
Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 StudyAdeel A Butt, Triin Umbleja, Janet W Andersen, et al.
The AIDS Reader|August 7, 2002
Serum LDH level as a clue to the diagnosis of histoplasmosisAdeel A Butt, Stephanie Michaels, Donald Greer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 2, 2016
Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVESAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Journal of Translational Medicine|April 14, 2018
Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank ProjectEhsan Ullah, Raghvendra Mall, Reda Rawi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2015
Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVESAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2019
Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES)Adeel A Butt, Peng Yan, Samia Aslam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2021
Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National PopulationAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Comparing Child-Pugh, MELD, and FIB-4 to Predict Clinical Outcomes in Hepatitis C Virus-Infected Persons: Results From ERCHIVESAdeel A Butt, Yanjie Ren, Vincent Lo Re, et al.
Annals of Internal Medicine|July 19, 2021
SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World SettingAdeel A Butt, Saad B Omer, Peng Yan, et al.
Pageof 26

Showing results (31-40 of 254) with videos related to

Sort By:
Pageof 26
The American Journal of the Medical Sciences|May 17, 2007
Biochemical and virologic parameters in patients co-infected with hepatitis C and HIV versus patients with hepatitis C mono-infectionAdeel A Butt, Joel Tsevat, Jawad Ahmad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2012
Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 StudyAdeel A Butt, Triin Umbleja, Janet W Andersen, et al.
The AIDS Reader|August 7, 2002
Serum LDH level as a clue to the diagnosis of histoplasmosisAdeel A Butt, Stephanie Michaels, Donald Greer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 2, 2016
Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVESAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Journal of Translational Medicine|April 14, 2018
Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank ProjectEhsan Ullah, Raghvendra Mall, Reda Rawi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2015
Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVESAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2019
Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES)Adeel A Butt, Peng Yan, Samia Aslam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2021
Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National PopulationAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Comparing Child-Pugh, MELD, and FIB-4 to Predict Clinical Outcomes in Hepatitis C Virus-Infected Persons: Results From ERCHIVESAdeel A Butt, Yanjie Ren, Vincent Lo Re, et al.
Annals of Internal Medicine|July 19, 2021
SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World SettingAdeel A Butt, Saad B Omer, Peng Yan, et al.
Pageof 26